Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate

Background Pre-eclampsia and the subsequent eclampsia account for a common cause of maternal mortality worldwide and efforts aimed at reducing its menace are vital. Objective To estimate the serum magnesium levels in pre-eclampsia and eclampsia and to study the effect of using different regimens of...

Full description

Bibliographic Details
Main Authors: Arpita Singh, Ajay Kumar Verma, Ghulam Hassan, Ved Prakash, P.Sharma, S.Kulshrestha
Format: Article
Language:English
Published: Makhdoomi Printers 2013-03-01
Series:Global Journal of Medicine and Public Health
Subjects:
Online Access:http://www.gjmedph.org/uploads/O4-Vo2No1.pdf
id doaj-5a7a74c9cb334502b9808933b6210802
record_format Article
spelling doaj-5a7a74c9cb334502b9808933b62108022020-11-25T02:44:01ZengMakhdoomi PrintersGlobal Journal of Medicine and Public Health 2277-96042013-03-010201Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate Arpita SinghAjay Kumar VermaGhulam HassanVed PrakashP.SharmaS.KulshresthaBackground Pre-eclampsia and the subsequent eclampsia account for a common cause of maternal mortality worldwide and efforts aimed at reducing its menace are vital. Objective To estimate the serum magnesium levels in pre-eclampsia and eclampsia and to study the effect of using different regimens of magnesium sulphate. Methods 70 cases of pre-eclampsia and eclampsia and 35 normal pregnant women as controls were studied. Serum magnesium levels were estimated using Atomic Absorption Spectrophotometer (Model AAS-4139) at baseline and at frequent intervals during gestation and the overall parameters were meticulously observed. Results Majority (60%) of studied cases was nullipara with gestation age of 36-40 weeks. Statistically significant reduction of mean diastolic blood pressure and protein-urea was observed after using both intramuscular and intravenous regimens of magnesium sulphate. Mean initial serum magnesium level (mg/dl)±SD was 1.81±0.58 in group A,1.55±0.41 in group B and 1.49±0.41 in group C. Mean serum magnesium levels during first 4 hours after therapy were statistically significant between intramuscular and intravenous regimen groups while same were statistically insignificant at 8,12,16,24 and 32 hours. Besides, few minor side effects including headache, vomiting, reduced tendon reflexes and thrombocytopenia, no severe side effects and no maternal mortality were seen. Conclusion Hypomagnesemia occurs during states of preeclampsia and eclampsia, and, administration of magnesium sulphate is effective and safe in preventing maternal mortality. http://www.gjmedph.org/uploads/O4-Vo2No1.pdfPre-eclampsiaeclampsiamaternal mortalitymagnesium sulphate
collection DOAJ
language English
format Article
sources DOAJ
author Arpita Singh
Ajay Kumar Verma
Ghulam Hassan
Ved Prakash
P.Sharma
S.Kulshrestha
spellingShingle Arpita Singh
Ajay Kumar Verma
Ghulam Hassan
Ved Prakash
P.Sharma
S.Kulshrestha
Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
Global Journal of Medicine and Public Health
Pre-eclampsia
eclampsia
maternal mortality
magnesium sulphate
author_facet Arpita Singh
Ajay Kumar Verma
Ghulam Hassan
Ved Prakash
P.Sharma
S.Kulshrestha
author_sort Arpita Singh
title Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
title_short Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
title_full Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
title_fullStr Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
title_full_unstemmed Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
title_sort serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate
publisher Makhdoomi Printers
series Global Journal of Medicine and Public Health
issn 2277-9604
publishDate 2013-03-01
description Background Pre-eclampsia and the subsequent eclampsia account for a common cause of maternal mortality worldwide and efforts aimed at reducing its menace are vital. Objective To estimate the serum magnesium levels in pre-eclampsia and eclampsia and to study the effect of using different regimens of magnesium sulphate. Methods 70 cases of pre-eclampsia and eclampsia and 35 normal pregnant women as controls were studied. Serum magnesium levels were estimated using Atomic Absorption Spectrophotometer (Model AAS-4139) at baseline and at frequent intervals during gestation and the overall parameters were meticulously observed. Results Majority (60%) of studied cases was nullipara with gestation age of 36-40 weeks. Statistically significant reduction of mean diastolic blood pressure and protein-urea was observed after using both intramuscular and intravenous regimens of magnesium sulphate. Mean initial serum magnesium level (mg/dl)±SD was 1.81±0.58 in group A,1.55±0.41 in group B and 1.49±0.41 in group C. Mean serum magnesium levels during first 4 hours after therapy were statistically significant between intramuscular and intravenous regimen groups while same were statistically insignificant at 8,12,16,24 and 32 hours. Besides, few minor side effects including headache, vomiting, reduced tendon reflexes and thrombocytopenia, no severe side effects and no maternal mortality were seen. Conclusion Hypomagnesemia occurs during states of preeclampsia and eclampsia, and, administration of magnesium sulphate is effective and safe in preventing maternal mortality.
topic Pre-eclampsia
eclampsia
maternal mortality
magnesium sulphate
url http://www.gjmedph.org/uploads/O4-Vo2No1.pdf
work_keys_str_mv AT arpitasingh serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
AT ajaykumarverma serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
AT ghulamhassan serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
AT vedprakash serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
AT psharma serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
AT skulshrestha serummagnesiumlevelsinpatientswithpreeclampsiaandeclampsiawithdifferentregimensofmagnesiumsulphate
_version_ 1724768079379955712